Our Leadership Team

Guido Oelkers
Chief Executive Officer

Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London, Complementary studies in Economics, London School of Economics and Political Science.

Other appointments: 

Previous positions: President and CEO, Gambro, CEO, Invida, a number of executive commercial operations roles in Nycomed, DKSH Group and Aventis, member of the Board of Directors at Meda.

Mats-Olof Wallin
Senior Vice President, Chief Financial Officer

Born 1951. Employed since 2013. B.Sc. at the University of Uppsala. 

Previous positions: More than 30 years of experience in the pharmaceutical industry, gained from various executive positions within companies such as Pharmacia, Ortivus and, most recently, Biotage AB (publ) where he held the role of CFO between 2003 and 2011. 

Carin Dahlquist
General Counsel and Head of Legal & Intellectual Property, Risk-, Safety and Environment Management

Born 1974. Employed since 2015. Master of Laws from the University of Lund, Sweden and New York University School of Law, USA.

Previous positions: Senior Legal Counsel at GE Healthcare Life Sciences 2006 - 2015. Legal Counsel at Q-Med AB, 2005-2006. Law firm Linklaters 2001-2005.

Lars Dreiøe
Senior Vice President, Chief Quality & Compliance Officer

Born 1967. Employed since 2016 M. Sc. University of Southern Denmark, Executive MBA from Copenhagen Business School. 

Previous positions: 20 years of experience from the biotech and pharmaceutical industry at Lundbeck and Novo Nordisk A/S. Lars joined Sobi from ALK where he held the position as International Head of Quality (2012-2015).

Kirsti Gjellan
Senior Vice President, Head of Biologics Development & Supply

Born 1963. Employed since 2014. M.Sc. in Pharmacy and PhD in Pharmaceutical Technology from the University of Oslo, Norway. 

Other appointments: Board member of Process Industrial IT and Automation (PiiA), the Swedish National mobilisation of management, innovation and competence

Previous positions: Site Leader Biologics Manufacturing, Managing Director of Pfizer Health AB and member of the Board of Pfizer Health AB 2010-2014. Director Quality Operations at Pfizer 2005-2010. Managerial experience from Pharmaceutical industry during 17 years with AstraZeneca covering Discovery, Proof of Concept, Pharmaceutical Development, Quality Operations in Manufacturing.

Armin Reininger
Senior Vice President, Medical and Scientific Affairs

Born 1957. Employed since 2017.  MD, PhD , Ludwig-Maximilians-University Munich, Germany; certified specialist in Transfusion Medicine

Previous positions: Baxter Head of Medical Affairs EMEA Hemophilia, Baxalta Head of Global Medical Affairs Hematology, Baxalta/Shire Head of Medical Affairs EMEA Hematology, Senior Physician University Clinic Munich, Dpt. of Transfusion Medicine and Haemostaseology. Visiting Scientist-Visiting Lecturer Harvard Medical School, Mass. General Hospital, Boston, MA, Visiting Fellow The Scripps Research Institute, La Jolla, CA, Professor of Anatomy at the Ludwig Maximilians-University Munich, Germany.

Dennis Schmidt Pedersen
Senior Vice President Human Resources

Born 1970. Employed since 2013. Educational background as officer, specialised in leadership development, analytical studies and tactics at the Royal Danish Officers Academy.

Previous positions: Long experience of transformation of local HR models to more integrated international operating models, gained from various leading HR positions in several international companies including Genzyme, Ferring Pharmaceuticals and A.P. Møller-Mærsk. Joined Sobi from Takeda, where he held the position as Director Human Resources, Northern Europe.

Milan Zdravkovic
Senior Vice President, Head of Research & Development

Born: 1970. Employed since: 2016 MD, PhD University of Aarhus, Denmark, MSc Pharmaceutical Medicine, University of Surrey, United Kingdom

Other appointments: DIA Advisory Council Europe, Middle East and Africa. Board member and co-founder of Selma Diagnostics Aps

Previous positions: Corporate Vice President, Novo Nordisk. 18 year tenure in the Research and Development organisation at Novo Nordisk responsible for therapeutic areas including diabetes, devices, growth hormone deficiency, obesity and immunology. Experience from early stage drug development to post-approval life-cycle management.

Opouštíte webové stránky SOBI

Společnost SOBI již dále nenese odpovědnost za obsah ani funkčnost internetových stránek jiných subjektů.

Přejete si opustit stránky?

Ano    Ne